Germ Cell Neoplasia in Situ and Preserved Fertility Despite Suppressed Gonadotropins in a Patient With Testotoxicosis
ContextTestotoxicosis is an autosomal-dominant, male-limited disorder. Activating mutations in the luteinizing hormone receptor gene (LHCGR) cause high autonomous testosterone secretion, resulting in early-onset peripheral precocious puberty. Little is known about long-term consequences of testotoxi...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2017-12, Vol.102 (12), p.4411-4416 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4416 |
---|---|
container_issue | 12 |
container_start_page | 4411 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 102 |
creator | Juel Mortensen, Li Blomberg Jensen, Martin Christiansen, Peter Rønholt, Ann-Margrethe Jørgensen, Anne Frederiksen, Hanne Nielsen, John E Loya, Anand C Grønkær Toft, Birgitte Skakkebæk, Niels E Rajpert-De Meyts, Ewa Juul, Anders |
description | ContextTestotoxicosis is an autosomal-dominant, male-limited disorder. Activating mutations in the luteinizing hormone receptor gene (LHCGR) cause high autonomous testosterone secretion, resulting in early-onset peripheral precocious puberty. Little is known about long-term consequences of testotoxicosis.Case DescriptionWe present a rare case of a patient followed for 25 years with two remarkable outcomes: preserved fertility and germ cell neoplasia in situ (GCNIS). He presented with precocious puberty at 10 months of age and was diagnosed with testotoxicosis due to a de novo heterozygous Asp578Tyr mutation in LHCGR. Testicular biopsy in childhood showed Leydig cell hyperplasia with altered cell maturation. From infancy throughout adulthood, elevated testosterone and estradiol, low inhibin B and anti-Müllerian hormone, and completely suppressed follicle-stimulating hormone and luteinizing hormone were noted. Height acceleration and advanced bone age resulted in a reduced final height. Semen analysis revealed ongoing spermatogenesis, and the patient fathered a child by natural conception. Ketoconazole treatment decreased circulating testosterone in childhood, supported by experimental suppression of testosterone production in his adult testis tissue cultured ex vivo. At 25 years of age, ultrasound revealed a testicular tumor, identified as a Leydig cell adenoma, but unexpectedly with GCNIS present in adjacent seminiferous tubules.ConclusionThe case illustrates that absence of gonadotropins but high intratesticular testosterone concentration is sufficient for spermatogenesis and to allow fatherhood. Our study is also the first description, to our knowledge, of GCNIS in a patient with testotoxicosis. We recommend regular clinical examination and ultrasonic evaluation of the testes in these patients due to potential increased risk of malignancy.A 25-year-old male with activating LHCGR mutation (testotoxicosis) was followed with clinical and biochemical evaluations from childhood and presented with testicular GCNIS lesions in adult life. |
doi_str_mv | 10.1210/jc.2017-01761 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1951417710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/jc.2017-01761</oup_id><sourcerecordid>3164375051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4631-e30db98e200b049968aeb68a851c18c64d9140a050b4cb0d96c10c6e539d2bfa3</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhi0EoqFw5IosceGyZcbr_fARpTQgVVCpRXCzvN6J4rBZL7aX0n-PQ1IOleDg8WEePTOjl7GXCGcoEN5u7ZkAbIr8anzEFqhkVTSomsdsASCwUI34dsKexbgFQCmr8ik7EQqEElIs2LyisONLGgb-ifw0mOgMdyO_dmnmZuz5VaBI4Sf1_IJCcoNLd_yc4uQS8et5mnI75ubKj6b3KfjJjXEvMPzKJEdj4l9d2vAbiskn_8tZH118zp6szRDpxfE_ZV8u3t8sPxSXn1cfl-8uCyvrEgsqoe9USwKgA6lU3RrqcmkrtNjaWvYKJRiooJO2g17VFsHWVJWqF93alKfszcE7Bf9jzivonYs2H2tG8nPUqCqU2DQIGX39AN36OYx5O11iLcumggr_RwkQZdsitE2migNlg48x0FpPwe1MuNMIep-a3lq9T03_SS3zr47WudtR_5e-jykDeABu_ZAoxO_DfEtBb8gMafNQWtxLj7f7efrX_CP6G1EBrY8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2023881087</pqid></control><display><type>article</type><title>Germ Cell Neoplasia in Situ and Preserved Fertility Despite Suppressed Gonadotropins in a Patient With Testotoxicosis</title><source>Journals@Ovid Ovid Autoload</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>ProQuest Central</source><creator>Juel Mortensen, Li ; Blomberg Jensen, Martin ; Christiansen, Peter ; Rønholt, Ann-Margrethe ; Jørgensen, Anne ; Frederiksen, Hanne ; Nielsen, John E ; Loya, Anand C ; Grønkær Toft, Birgitte ; Skakkebæk, Niels E ; Rajpert-De Meyts, Ewa ; Juul, Anders</creator><creatorcontrib>Juel Mortensen, Li ; Blomberg Jensen, Martin ; Christiansen, Peter ; Rønholt, Ann-Margrethe ; Jørgensen, Anne ; Frederiksen, Hanne ; Nielsen, John E ; Loya, Anand C ; Grønkær Toft, Birgitte ; Skakkebæk, Niels E ; Rajpert-De Meyts, Ewa ; Juul, Anders</creatorcontrib><description>ContextTestotoxicosis is an autosomal-dominant, male-limited disorder. Activating mutations in the luteinizing hormone receptor gene (LHCGR) cause high autonomous testosterone secretion, resulting in early-onset peripheral precocious puberty. Little is known about long-term consequences of testotoxicosis.Case DescriptionWe present a rare case of a patient followed for 25 years with two remarkable outcomes: preserved fertility and germ cell neoplasia in situ (GCNIS). He presented with precocious puberty at 10 months of age and was diagnosed with testotoxicosis due to a de novo heterozygous Asp578Tyr mutation in LHCGR. Testicular biopsy in childhood showed Leydig cell hyperplasia with altered cell maturation. From infancy throughout adulthood, elevated testosterone and estradiol, low inhibin B and anti-Müllerian hormone, and completely suppressed follicle-stimulating hormone and luteinizing hormone were noted. Height acceleration and advanced bone age resulted in a reduced final height. Semen analysis revealed ongoing spermatogenesis, and the patient fathered a child by natural conception. Ketoconazole treatment decreased circulating testosterone in childhood, supported by experimental suppression of testosterone production in his adult testis tissue cultured ex vivo. At 25 years of age, ultrasound revealed a testicular tumor, identified as a Leydig cell adenoma, but unexpectedly with GCNIS present in adjacent seminiferous tubules.ConclusionThe case illustrates that absence of gonadotropins but high intratesticular testosterone concentration is sufficient for spermatogenesis and to allow fatherhood. Our study is also the first description, to our knowledge, of GCNIS in a patient with testotoxicosis. We recommend regular clinical examination and ultrasonic evaluation of the testes in these patients due to potential increased risk of malignancy.A 25-year-old male with activating LHCGR mutation (testotoxicosis) was followed with clinical and biochemical evaluations from childhood and presented with testicular GCNIS lesions in adult life.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2017-01761</identifier><identifier>PMID: 29029242</identifier><language>eng</language><publisher>Washington, DC: Endocrine Society</publisher><subject>17β-Estradiol ; Adenoma ; Adult ; Age ; Biopsy ; Body Composition ; Body Height ; Bone and Bones - pathology ; Children ; Fertility ; Follicle-stimulating hormone ; Gonadotropins ; Gonadotropins - metabolism ; Hereditary diseases ; Hormone Antagonists - therapeutic use ; Humans ; Hyperplasia ; Inhibin ; Ketoconazole ; Ketoconazole - therapeutic use ; Lesions ; Leydig Cell Tumor - complications ; Leydig Cell Tumor - genetics ; Leydig Cell Tumor - pathology ; Luteinizing hormone ; Male ; Malignancy ; Mutation ; Neoplasms, Germ Cell and Embryonal - complications ; Neoplasms, Germ Cell and Embryonal - genetics ; Neoplasms, Germ Cell and Embryonal - pathology ; Patients ; Pituitary (anterior) ; Puberty ; Puberty, Precocious - complications ; Puberty, Precocious - etiology ; Receptors, LH - genetics ; Semen ; Spermatogenesis ; Testes ; Testicular cancer ; Testis - diagnostic imaging ; Testis - metabolism ; Testosterone ; Tubules ; Ultrasound</subject><ispartof>The journal of clinical endocrinology and metabolism, 2017-12, Vol.102 (12), p.4411-4416</ispartof><rights>Copyright © 2017 Endocrine Society 2017</rights><rights>Copyright © Oxford University Press 2015</rights><rights>Copyright © 2017 Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4631-e30db98e200b049968aeb68a851c18c64d9140a050b4cb0d96c10c6e539d2bfa3</citedby><cites>FETCH-LOGICAL-c4631-e30db98e200b049968aeb68a851c18c64d9140a050b4cb0d96c10c6e539d2bfa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2023881087?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,21367,27901,27902,33721,33722,43781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29029242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Juel Mortensen, Li</creatorcontrib><creatorcontrib>Blomberg Jensen, Martin</creatorcontrib><creatorcontrib>Christiansen, Peter</creatorcontrib><creatorcontrib>Rønholt, Ann-Margrethe</creatorcontrib><creatorcontrib>Jørgensen, Anne</creatorcontrib><creatorcontrib>Frederiksen, Hanne</creatorcontrib><creatorcontrib>Nielsen, John E</creatorcontrib><creatorcontrib>Loya, Anand C</creatorcontrib><creatorcontrib>Grønkær Toft, Birgitte</creatorcontrib><creatorcontrib>Skakkebæk, Niels E</creatorcontrib><creatorcontrib>Rajpert-De Meyts, Ewa</creatorcontrib><creatorcontrib>Juul, Anders</creatorcontrib><title>Germ Cell Neoplasia in Situ and Preserved Fertility Despite Suppressed Gonadotropins in a Patient With Testotoxicosis</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>ContextTestotoxicosis is an autosomal-dominant, male-limited disorder. Activating mutations in the luteinizing hormone receptor gene (LHCGR) cause high autonomous testosterone secretion, resulting in early-onset peripheral precocious puberty. Little is known about long-term consequences of testotoxicosis.Case DescriptionWe present a rare case of a patient followed for 25 years with two remarkable outcomes: preserved fertility and germ cell neoplasia in situ (GCNIS). He presented with precocious puberty at 10 months of age and was diagnosed with testotoxicosis due to a de novo heterozygous Asp578Tyr mutation in LHCGR. Testicular biopsy in childhood showed Leydig cell hyperplasia with altered cell maturation. From infancy throughout adulthood, elevated testosterone and estradiol, low inhibin B and anti-Müllerian hormone, and completely suppressed follicle-stimulating hormone and luteinizing hormone were noted. Height acceleration and advanced bone age resulted in a reduced final height. Semen analysis revealed ongoing spermatogenesis, and the patient fathered a child by natural conception. Ketoconazole treatment decreased circulating testosterone in childhood, supported by experimental suppression of testosterone production in his adult testis tissue cultured ex vivo. At 25 years of age, ultrasound revealed a testicular tumor, identified as a Leydig cell adenoma, but unexpectedly with GCNIS present in adjacent seminiferous tubules.ConclusionThe case illustrates that absence of gonadotropins but high intratesticular testosterone concentration is sufficient for spermatogenesis and to allow fatherhood. Our study is also the first description, to our knowledge, of GCNIS in a patient with testotoxicosis. We recommend regular clinical examination and ultrasonic evaluation of the testes in these patients due to potential increased risk of malignancy.A 25-year-old male with activating LHCGR mutation (testotoxicosis) was followed with clinical and biochemical evaluations from childhood and presented with testicular GCNIS lesions in adult life.</description><subject>17β-Estradiol</subject><subject>Adenoma</subject><subject>Adult</subject><subject>Age</subject><subject>Biopsy</subject><subject>Body Composition</subject><subject>Body Height</subject><subject>Bone and Bones - pathology</subject><subject>Children</subject><subject>Fertility</subject><subject>Follicle-stimulating hormone</subject><subject>Gonadotropins</subject><subject>Gonadotropins - metabolism</subject><subject>Hereditary diseases</subject><subject>Hormone Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Inhibin</subject><subject>Ketoconazole</subject><subject>Ketoconazole - therapeutic use</subject><subject>Lesions</subject><subject>Leydig Cell Tumor - complications</subject><subject>Leydig Cell Tumor - genetics</subject><subject>Leydig Cell Tumor - pathology</subject><subject>Luteinizing hormone</subject><subject>Male</subject><subject>Malignancy</subject><subject>Mutation</subject><subject>Neoplasms, Germ Cell and Embryonal - complications</subject><subject>Neoplasms, Germ Cell and Embryonal - genetics</subject><subject>Neoplasms, Germ Cell and Embryonal - pathology</subject><subject>Patients</subject><subject>Pituitary (anterior)</subject><subject>Puberty</subject><subject>Puberty, Precocious - complications</subject><subject>Puberty, Precocious - etiology</subject><subject>Receptors, LH - genetics</subject><subject>Semen</subject><subject>Spermatogenesis</subject><subject>Testes</subject><subject>Testicular cancer</subject><subject>Testis - diagnostic imaging</subject><subject>Testis - metabolism</subject><subject>Testosterone</subject><subject>Tubules</subject><subject>Ultrasound</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kU1vEzEQhi0EoqFw5IosceGyZcbr_fARpTQgVVCpRXCzvN6J4rBZL7aX0n-PQ1IOleDg8WEePTOjl7GXCGcoEN5u7ZkAbIr8anzEFqhkVTSomsdsASCwUI34dsKexbgFQCmr8ik7EQqEElIs2LyisONLGgb-ifw0mOgMdyO_dmnmZuz5VaBI4Sf1_IJCcoNLd_yc4uQS8et5mnI75ubKj6b3KfjJjXEvMPzKJEdj4l9d2vAbiskn_8tZH118zp6szRDpxfE_ZV8u3t8sPxSXn1cfl-8uCyvrEgsqoe9USwKgA6lU3RrqcmkrtNjaWvYKJRiooJO2g17VFsHWVJWqF93alKfszcE7Bf9jzivonYs2H2tG8nPUqCqU2DQIGX39AN36OYx5O11iLcumggr_RwkQZdsitE2migNlg48x0FpPwe1MuNMIep-a3lq9T03_SS3zr47WudtR_5e-jykDeABu_ZAoxO_DfEtBb8gMafNQWtxLj7f7efrX_CP6G1EBrY8</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Juel Mortensen, Li</creator><creator>Blomberg Jensen, Martin</creator><creator>Christiansen, Peter</creator><creator>Rønholt, Ann-Margrethe</creator><creator>Jørgensen, Anne</creator><creator>Frederiksen, Hanne</creator><creator>Nielsen, John E</creator><creator>Loya, Anand C</creator><creator>Grønkær Toft, Birgitte</creator><creator>Skakkebæk, Niels E</creator><creator>Rajpert-De Meyts, Ewa</creator><creator>Juul, Anders</creator><general>Endocrine Society</general><general>Copyright Oxford University Press</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20171201</creationdate><title>Germ Cell Neoplasia in Situ and Preserved Fertility Despite Suppressed Gonadotropins in a Patient With Testotoxicosis</title><author>Juel Mortensen, Li ; Blomberg Jensen, Martin ; Christiansen, Peter ; Rønholt, Ann-Margrethe ; Jørgensen, Anne ; Frederiksen, Hanne ; Nielsen, John E ; Loya, Anand C ; Grønkær Toft, Birgitte ; Skakkebæk, Niels E ; Rajpert-De Meyts, Ewa ; Juul, Anders</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4631-e30db98e200b049968aeb68a851c18c64d9140a050b4cb0d96c10c6e539d2bfa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>17β-Estradiol</topic><topic>Adenoma</topic><topic>Adult</topic><topic>Age</topic><topic>Biopsy</topic><topic>Body Composition</topic><topic>Body Height</topic><topic>Bone and Bones - pathology</topic><topic>Children</topic><topic>Fertility</topic><topic>Follicle-stimulating hormone</topic><topic>Gonadotropins</topic><topic>Gonadotropins - metabolism</topic><topic>Hereditary diseases</topic><topic>Hormone Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Inhibin</topic><topic>Ketoconazole</topic><topic>Ketoconazole - therapeutic use</topic><topic>Lesions</topic><topic>Leydig Cell Tumor - complications</topic><topic>Leydig Cell Tumor - genetics</topic><topic>Leydig Cell Tumor - pathology</topic><topic>Luteinizing hormone</topic><topic>Male</topic><topic>Malignancy</topic><topic>Mutation</topic><topic>Neoplasms, Germ Cell and Embryonal - complications</topic><topic>Neoplasms, Germ Cell and Embryonal - genetics</topic><topic>Neoplasms, Germ Cell and Embryonal - pathology</topic><topic>Patients</topic><topic>Pituitary (anterior)</topic><topic>Puberty</topic><topic>Puberty, Precocious - complications</topic><topic>Puberty, Precocious - etiology</topic><topic>Receptors, LH - genetics</topic><topic>Semen</topic><topic>Spermatogenesis</topic><topic>Testes</topic><topic>Testicular cancer</topic><topic>Testis - diagnostic imaging</topic><topic>Testis - metabolism</topic><topic>Testosterone</topic><topic>Tubules</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Juel Mortensen, Li</creatorcontrib><creatorcontrib>Blomberg Jensen, Martin</creatorcontrib><creatorcontrib>Christiansen, Peter</creatorcontrib><creatorcontrib>Rønholt, Ann-Margrethe</creatorcontrib><creatorcontrib>Jørgensen, Anne</creatorcontrib><creatorcontrib>Frederiksen, Hanne</creatorcontrib><creatorcontrib>Nielsen, John E</creatorcontrib><creatorcontrib>Loya, Anand C</creatorcontrib><creatorcontrib>Grønkær Toft, Birgitte</creatorcontrib><creatorcontrib>Skakkebæk, Niels E</creatorcontrib><creatorcontrib>Rajpert-De Meyts, Ewa</creatorcontrib><creatorcontrib>Juul, Anders</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Juel Mortensen, Li</au><au>Blomberg Jensen, Martin</au><au>Christiansen, Peter</au><au>Rønholt, Ann-Margrethe</au><au>Jørgensen, Anne</au><au>Frederiksen, Hanne</au><au>Nielsen, John E</au><au>Loya, Anand C</au><au>Grønkær Toft, Birgitte</au><au>Skakkebæk, Niels E</au><au>Rajpert-De Meyts, Ewa</au><au>Juul, Anders</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Germ Cell Neoplasia in Situ and Preserved Fertility Despite Suppressed Gonadotropins in a Patient With Testotoxicosis</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>102</volume><issue>12</issue><spage>4411</spage><epage>4416</epage><pages>4411-4416</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>ContextTestotoxicosis is an autosomal-dominant, male-limited disorder. Activating mutations in the luteinizing hormone receptor gene (LHCGR) cause high autonomous testosterone secretion, resulting in early-onset peripheral precocious puberty. Little is known about long-term consequences of testotoxicosis.Case DescriptionWe present a rare case of a patient followed for 25 years with two remarkable outcomes: preserved fertility and germ cell neoplasia in situ (GCNIS). He presented with precocious puberty at 10 months of age and was diagnosed with testotoxicosis due to a de novo heterozygous Asp578Tyr mutation in LHCGR. Testicular biopsy in childhood showed Leydig cell hyperplasia with altered cell maturation. From infancy throughout adulthood, elevated testosterone and estradiol, low inhibin B and anti-Müllerian hormone, and completely suppressed follicle-stimulating hormone and luteinizing hormone were noted. Height acceleration and advanced bone age resulted in a reduced final height. Semen analysis revealed ongoing spermatogenesis, and the patient fathered a child by natural conception. Ketoconazole treatment decreased circulating testosterone in childhood, supported by experimental suppression of testosterone production in his adult testis tissue cultured ex vivo. At 25 years of age, ultrasound revealed a testicular tumor, identified as a Leydig cell adenoma, but unexpectedly with GCNIS present in adjacent seminiferous tubules.ConclusionThe case illustrates that absence of gonadotropins but high intratesticular testosterone concentration is sufficient for spermatogenesis and to allow fatherhood. Our study is also the first description, to our knowledge, of GCNIS in a patient with testotoxicosis. We recommend regular clinical examination and ultrasonic evaluation of the testes in these patients due to potential increased risk of malignancy.A 25-year-old male with activating LHCGR mutation (testotoxicosis) was followed with clinical and biochemical evaluations from childhood and presented with testicular GCNIS lesions in adult life.</abstract><cop>Washington, DC</cop><pub>Endocrine Society</pub><pmid>29029242</pmid><doi>10.1210/jc.2017-01761</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2017-12, Vol.102 (12), p.4411-4416 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_proquest_miscellaneous_1951417710 |
source | Journals@Ovid Ovid Autoload; Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; ProQuest Central |
subjects | 17β-Estradiol Adenoma Adult Age Biopsy Body Composition Body Height Bone and Bones - pathology Children Fertility Follicle-stimulating hormone Gonadotropins Gonadotropins - metabolism Hereditary diseases Hormone Antagonists - therapeutic use Humans Hyperplasia Inhibin Ketoconazole Ketoconazole - therapeutic use Lesions Leydig Cell Tumor - complications Leydig Cell Tumor - genetics Leydig Cell Tumor - pathology Luteinizing hormone Male Malignancy Mutation Neoplasms, Germ Cell and Embryonal - complications Neoplasms, Germ Cell and Embryonal - genetics Neoplasms, Germ Cell and Embryonal - pathology Patients Pituitary (anterior) Puberty Puberty, Precocious - complications Puberty, Precocious - etiology Receptors, LH - genetics Semen Spermatogenesis Testes Testicular cancer Testis - diagnostic imaging Testis - metabolism Testosterone Tubules Ultrasound |
title | Germ Cell Neoplasia in Situ and Preserved Fertility Despite Suppressed Gonadotropins in a Patient With Testotoxicosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T04%3A15%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Germ%20Cell%20Neoplasia%20in%20Situ%20and%20Preserved%20Fertility%20Despite%20Suppressed%20Gonadotropins%20in%20a%20Patient%20With%20Testotoxicosis&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Juel%20Mortensen,%20Li&rft.date=2017-12-01&rft.volume=102&rft.issue=12&rft.spage=4411&rft.epage=4416&rft.pages=4411-4416&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/jc.2017-01761&rft_dat=%3Cproquest_cross%3E3164375051%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2023881087&rft_id=info:pmid/29029242&rft_oup_id=10.1210/jc.2017-01761&rfr_iscdi=true |